| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |